Resveratrol’s anticancer evolution: a global patent landscape analysis

Authors

  • Yang Lu International Sacharov Environmental Institute of Belarusian State University , International Sakharov Environmental Institute, Belarusian State University , The Yancheng Clinical College of Xuzhou Medical University (The First People’s Hospital of Yancheng), Department of Gynecology and Obstetrics
  • Sergei V. Petrenko International Sakharov Environmental Institute, Belarusian State University

Keywords:

patent analysis, resveratrol, anticancer drugs, molecular optimization, bioavailability enhancement

Abstract

Resveratrol, a naturally occurring phenolic compound with diverse biological activities including anticancer, anti-inflammatory, and neuroprotective effects, has long faced obstacles in clinical translation due to its low bioavailability, chemical instability, and rapid metabolism. Based on global patent data, this study provides an in-depth analysis of the patent landscape of resveratrol in the field of cancer therapy, focusing on competitive players, technological evolution, and strategic development trends. Particular emphasis is placed on how academia and industry have attempted to overcome application bottlenecks through molecular structural modification, synergistic combination therapies, and advanced nanodelivery systems. This analysis aims to offer strategic insights for the future development and clinical application of resveratrol-based anticancer drugs.

Author Biographies

  • Yang Lu, International Sacharov Environmental Institute of Belarusian State University, International Sakharov Environmental Institute, Belarusian State University, The Yancheng Clinical College of Xuzhou Medical University (The First People’s Hospital of Yancheng), Department of Gynecology and Obstetrics

    graduate student at the department of ecological medicine and radiobiology; department of gynecology and obstetrics, the first people’s hospital of Yancheng

  • Sergei V. Petrenko, International Sakharov Environmental Institute, Belarusian State University

    PhD (medicine), docent; associate professor at the department of ecological medicine and radiobiology

References

  1. Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: A literature review. International journal of molecular sciences. 2020;21(6):2084. https://doi.org/10.3390/ijms21062084.
  2. Kaur A, Tiwari R, Tiwari G, et al. Resveratrol: A vital therapeutic agent with multiple health benefits. Drug research. 2022;72(01):5– 17.https://doi.org/10.1055/a-1555-2919.
  3. Liu X, Pei J, Li J, et al. Recent Advances in Resveratrol Derivatives: Structural Modifications and Biological Activities. Molecules. 2025;30(4):958. https://doi.org/10.3390/molecules30040958. PMID:40005268;PMCID: PMC11858244.
  4. Agbadua, OG, Kúsz, N, Berkecz R, et al. New Insights into the French Paradox: Free Radical Scavenging by Resveratrol Yields Cardiovascular Protective Metabolites. Journal of Medicinal Chemistry. 2025;68(10):10031–10047. https://doi.org/10.1021/acs.jmedchem.4c03061.
  5. Jang M， Cai L， Udeani GO, et al. Cancer chemopreventive activity of resveratrol natural product derived from grapes. Science. 1997;275:218–200. https://doi.org/10.1126/science.275.5297.218.
  6. Grzeczka A, Graczyk S, Kordowitzki P. Pleiotropic Effects of Resveratrol on Aging-Related Cardiovascular Diseases—What Can We Learn from Research in Dogs? Cells. 2024;13(20):1732. https://doi.org/10.3390/cells13201732.
  7. Xu G, Chen J, Wang G, et al. Resveratrol inhibits the tumorigenesis of follicular thyroid cancer via ST6GAL2-regulated activation of the hippo signaling pathway. Molecular Therapy-Oncolytics. 2020;16:124–133. http://creativecommons.org/licenses/by-nc-nd/4.0/
  8. Yee YJ, Benson HA, Dass CR, et al. Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo. International Journal of Pharmaceutics. 2022:615:121499. https://doi.org/10.1016/j.ijpharm.2022.121499.
  9. Riccio BV, Spósito L, Carvalho GC, et al. Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body. Archiv der Pharmazie. 2020;353(12):2000146. https://doi.org/10.1002/ardp.202000146.
  10. Tom D, Mareike DH, Karel D, et al. Patent No. 10,280,442 Mutant sucrose phosphorylases with improved glycosylation activity towards polyphenols. U.S., Patent and Trademark Office, 2019.
  11. Li C, Xu, X, Tao Z, et al. Resveratrol derivatives: an updated patent review (2012–2015). Expert Opinion on Therapeutic Patents. 2016;26(10):1189–1200. https://doi.org/10.1080/13543776.2016.1215435.
  12. Xu Y, Gao Y, Yang M, et al. Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors. Future Medicinal Chemistry. 2021;13(17): 1415–1433. https://doi.org/10.4155/fmc-2021-0105.
  13. Arena A, Romeo, MA, Benedetti R, et al. New insights into curcumin-and resveratrol-mediated anti-cancer effects. Pharmaceuticals. 2021;14(11):1068. https://doi.org/10.3390/ph14111068.
  14. Unnikrishnan Meenakshi D, Narde, GK, Ahuja A, et al. Therapeutic applications of nanoformulated resveratrol and quercetin phytochemicals in colorectal cancer – an updated review. Pharmaceutics. 2024;16(6):761. https://doi.org/10.3390/pharmaceutics16060761.
  15. Mirzaei S, Gholami MH, Zabolian A, et al. Resveratrol augments doxorubicin and cisplatin chemotherapy: a novel therapeutic strategy. Current molecular pharmacology. 2023:16(3);280–306. https://doi.org/10.2174/1874467215666220415131344.
  16. Alanazi AM, Fadda L, Alhusaini A, et al. Liposomal resveratrol and/or carvedilol attenuate doxorubicin-induced cardiotoxicity by modulating inflammation, oxidative stress and S100A1 in rats. Antioxidants. 2020;9(2):159. https://doi.org/10.3390/antiox9020159.
  17. Zhang X, Han L, Sun Q, et al. Controlled release of resveratrol and xanthohumol via coaxial electrospinning fibers. Journal of Biomaterials Science, Polymer Edition. 2020;31(4):456–471. https://doi.org/10.1080/09205063.2019.1700600.
  18. Li C, Wang Z, Lei H, et al. Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Delivery. 2023;30(1). https://doi.org/10.1080/10717544.2023.2174206.
  19. Bao R, Wang T, & Jiang W. Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells. Biomolecules. 2026;16(1):118. https://doi.org/10.3390/biom16010118.
  20. Gao Y, Wang YY, Wang BD, et al. Mechanism of Action of Resveratrol Affecting the Biological Function of Breast Cancer Through the Glycolytic Pathway. World Journal Oncology. 2025;16(4):375–387. https://doi.org/10.14740/wjon2586. PMID: 40810082; PMCID: PMC12339261.
  21. Kursvietiene L, Kopustinskiene DM, Staneviciene I, et al. Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions. Antioxidants. 2023;12(12):2056. https://doi.org/10.3390/antiox12122056.
  22. Raviv T, Shteinfer-Kuzmine A, Moyal MM, et al. Resveratrol’s Pro-Apoptotic Effects in Cancer Are Mediated Through the Interaction and Oligomerization of the Mitochondrial VDAC1. International Journal of Molecular Sciences. 2025;26(9):3963. https://doi.org/10.3390/ijms26093963.
  23. Khanvilkar S, Mittra I. Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin. Pharmaceuticals. 2025;18(1):132. https://doi.org/10.3390/ph18010132.
  24. Szymkowiak I, Marcinkowska J, Kucinska M, et al. Resveratrol Bioavailability After Oral Administration: A Meta-Analysis of Clinical Trial Data. Phytotherapy Research. 2025;39(1):453–464. https://doi.org/10.1002/ptr.8379. Epub 2024 Nov 18. PMID: 39557444.
  25. Qin H. Resveratrol: A promising agent in targeting senescent cancer-associated fibroblasts to inhibit pancreatic cancer progression. World Journal Gastrointest Oncology. 2025;17(7):105034. https://doi.org/10.4251/wjgo.v17.i7.105034. PMID: 40697227; PMCID: PMC12278224.

Downloads

Published

2026-11-11

Issue

No. 3 (2026): ЖУРНАЛ БЕЛОРУССКОГО ГОСУДАРСТВЕННОГО УНИВЕРСИТЕТА ЭКОЛОГИЯ

Section

Applied ecology (medical ecology, industrial ecology, agrarian ecology, forestry ecology, water management ecology, etc.)

How to Cite

[1]
Lu, Y. and Petrenko, S.V. 2026. Resveratrol’s anticancer evolution: a global patent landscape analysis. Journal of the Belarusian State University. Ecology. 3 (Nov. 2026).